药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Furazabol
Pibrentasvir
The serum concentration of Copanlisib can be increased when it is combined with Pibrentasvir.
Furazabol
Enasidenib
The serum concentration of Copanlisib can be increased when it is combined with Enasidenib.
Furazabol
Laniquidar
The serum concentration of Copanlisib can be increased when it is combined with Laniquidar.
Furazabol
Brefeldin A
The serum concentration of Copanlisib can be increased when it is combined with Brefeldin A.
Furazabol
Darolutamide
Darolutamide may decrease the excretion rate of Copanlisib which could result in a higher serum level.
Furazabol
Metreleptin
The metabolism of Copanlisib can be increased when combined with Metreleptin.
Furazabol
Armodafinil
The metabolism of Copanlisib can be increased when combined with Armodafinil.
Furazabol
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Copanlisib.
Furazabol
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Copanlisib.
17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Favipiravir.
17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane
Pralsetinib
The serum concentration of Pralsetinib can be increased when it is combined with Favipiravir.
17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane
Ubrogepant
The serum concentration of Ubrogepant can be increased when it is combined with Favipiravir.
17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane
Lefamulin
Favipiravir may decrease the excretion rate of Lefamulin which could result in a higher serum level.
17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane
Acetyldigoxin
Favipiravir may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.
17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane
Metildigoxin
Favipiravir may decrease the excretion rate of Metildigoxin which could result in a higher serum level.
17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane
Enasidenib
The metabolism of Enasidenib can be decreased when combined with Favipiravir.
17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane
Tegafur
The metabolism of Tegafur can be decreased when combined with Favipiravir.
17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane
Ozanimod
The metabolism of Ozanimod can be decreased when combined with Favipiravir.
17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane
(S)-Warfarin
The metabolism of (S)-Warfarin can be decreased when combined with Favipiravir.
17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane
Estradiol valerate
The metabolism of Estradiol valerate can be decreased when combined with Favipiravir.